AHC Ballana Heart Study
ConditionGenetic Predisposition to Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMagdi Yacoub Heart Foundation
About this trial
This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Residents of Ballana from the 1,200 randomly selected households
Participants must have a valid National ID card
Written informed consent
Disqualifiers
None
Trial population
• Residents of Ballana from the 1,200 randomly selected households
Trial design
Design model
Ecologic or community
Time perspective
Prospective
Treatments tested in this trial
Risk assessment
Other interventionCollect clinical, laboratoary and genetics data from the participants after informed consent
Treatment groups
5,000 Participants
are divided into 1 treatment groupGroup A: BHS1 intervention
Trial outcomes
Primary outcomes
1
Cardiovascular risk assessment
Time frame
30 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov